Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: Systematic review and meta-analysis of randomized, controlled trials

Clinical Infectious Diseases

Volumn 47, Issue 1, 2008, Pages 83-93

  Yahav, Dafna ^a,b   Rozen Zvi, Benaya ^a,b   Gafter Gvili, Anat ^a,b   Leibovici, Leonard ^a,b   Gafter, Uzi ^a   Paul, Mical ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFOTAXIME; CITRIC ACID; EDETIC ACID; GENTAMICIN; HEPARIN; IODINE; METICILLIN; MINOCYCLINE; PSEUDOMONIC ACID; TAUROLIDINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CATHETER INFECTION; CATHETER REMOVAL; CLINICAL TRIAL; DISEASE ASSOCIATION; DIZZINESS; DRUG WITHDRAWAL; HEMODIALYSIS; HUMAN; INTRAVASCULAR CATHETER; META ANALYSIS; MONOTHERAPY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RASH; RISK FACTOR; SEPSIS; STAPHYLOCOCCUS INFECTION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VERTIGO; ANIMAL; BACTEREMIA; CROSS INFECTION; DISINFECTION; INDWELLING CATHETER; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTEREMIA; CATHETERS, INDWELLING; CROSS INFECTION; DISINFECTION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS;

EID: 46249086815     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/588667     Document Type: Article

References (63)

1. Katneni R, Hedayati SS. Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat Clin Pract Nephrol 2007; 3:256-66.
2. US Renal Data System. USRDS 2003 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003.
3. Randolph AG, Cook DJ, Gonzales CA, Brun-Buisson C. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med 1998; 26:1452-7.
4. Timsit JF, Bruneel F, Cheval C, et al. Use of tunneled femoral catheters to prevent catheter-related infection: a randomized, controlled trial. Ann Intern Med 1999; 130:729-35.
5. Flowers RH III, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection: a randomized, controlled trial. JAMA 1989; 261:878-83.
6. Fong IW. Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidone-iodine. Postgrad Med J 1993; 69(Suppl 3):S15-7.
7. Johnson DW, MacGinley R, Kay TD, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002; 17:1802-7.
8. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991; 40:934-8.
9. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003; 14:169-79.
10. Sesso R, Barbosa D, Leme IL, et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 1998; 9:1085-92.
11. Boelaert JR, De Smedt RA, De Baere YA, et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 1989; 4:278-81.
12. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EM. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003;37:1629-38.
13. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315:91-6.
14. Dahlberg PJ, Agger WA, Singer JR, et al. Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol 1995; 16:506-11.
15. Trerotola SO, Johnson MS, Shah H, et al. Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection: a randomized study. Radiology 1998; 207:491-6.
16. Chatzinikolaou I, Finkel K, Hanna H, et al. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med 2003; 115:352-7.
17. Raad I, Hachem R, Tcholakian RK, Sherertz R. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 2002; 46:327-32.
18. Raad I, Hanna H, Jiang Y, et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 2007; 51:1656-60.
19. Sherertz RJ, Boger MS, Collins CA, Mason L, Raad II. Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 2006; 50:1865-8.
20. National Kidney Foundation. National kidney foundation clinical practice guidelines and clinical practice recommendations for 2006 updates: HD adequacy, peritoneal dialysis adequacy and vascular access. Available at: http://www.kidney.org/professional/Kdoqi/guideline_upHD_PD_VA/index.htm:S1-S322. Accessed 17 May 2008.
21. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002; 51:1-29.
22. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions 4.2.5: updated May 2005. Chichester, UK: John Wiley & Sons, 2007.
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60.
24. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003; 36:1539-44.
25. Ash S, Mannkus R, Sutton J, et al. Concentrated sodium citrate as a catheter lock solution [abstract]. J Am Soc Nephrol 1999; 10:272A.
26. Bleyer A, Mason L, Raad I, Sherertz RJ. A randomized, double-blind trial comparing heparin vs minocycline/EDTA as flush solutions for hemodialysis catheters [abstract P-S1-31]. In: Program and abstracts of the Fourth Decennial International Conference of Nosocomial and Healthcare-Associated Infections (Atlanta). 2000:91.
27. Buturovic J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P. Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artif Organs 1998; 22:945-7.
28. Chiou PF, Chang CC, Wen YK, Yang Y. Antibiotic lock technique reduces the incidence of temporary catheter-related infections. Clin Nephrol 2006; 65:419-22.
29. Fluck R, Taal M, McIntyre C. A single centre, one-year experience with antibiotic locking for tunnelled venous catheters. Nephrol Dial Transplant 2006; 21(Suppl 4):iv459-60.
30. Geron R, Tanchilevski O, Kristal B. Catheter lock solution: taurolock for prevention of catheter-related bacteremia in hemodialysis patients [in Hebrew]. Harefuah 2006; 145:881-943.
31. Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous dialysis catheters: an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant 2007; 22:471-6.
32. Jurewitsch B, Lee T, Park J, Jeejeebhoy K. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. JPEN J Parenter Enteral Nutr 1998; 22:242-4.
33. Lambie SH, Hulme LJ, Taal M, Fluck RJ, McIntyre CW. Prospective study of gentamicin locking of tunnelled dialysis catheters: the effect on infection rates and CRP. Kidney Int 2005; 67:378.
34. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM. Trisodium citrate 4%: an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 2007; 22:477-83.
35. Lynn RI. Reduced incidence of hemodialysis (HD) catheters related bacteremia (CRB) using a weekly citrate-gentamycin lock [abstract 1006]. J Am Soc Nephrol 2000; 11:189A.
36. Meeus G, Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y. A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters. Blood Purif 2005; 23:101-5.
37. Nori US, Fisher KA, Osman Y, Manoharan A, Besarab A. Efficacy of antibiotic lock solutions in preventing hemodialysis catheter related bacteremia [abstract SU-FC076]. J Am Soc Nephrol 2004; 15:60A.
38. Saxena AK, Panhotra BR, Sundaram DS, et al. Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int 2006; 70:1629-35.
39. Schwab SJ, Weiss MA, Rushton F, et al. Multicenter clinical trial results with the LifeSite hemodialysis access system. Kidney Int 2002; 62:1026-33.
40. Sodemann K, Lubrich-Birkner I, Berger O, Baumert J, Feldmer B, Von Hodenberg E. Gentamicin/sodium-citrate mixture as antibiotic-lock technique for salvage and prevention of catheter-related infections: a four year trial. J Am Soc Nephrol 1997; 8:173A.
41. Stas KJ, Vanwalleghem J, De Moor B, Keuleers H. Trisodium citrate 30% vs. heparin 5% as catheter lock in the interdialytic period in twinor double-lumen dialysis catheters for intermittent haemodialysis. Nephrol Dial Transplant 2001; 16:1521-2.
42. Weijmer M, van den Dorpel R, van Geelen J, et al. Substantial reduction of infectious complications in hemodialysis patients with trisodium citrate 30% as catheter locking solution: a prospective multicenter double-blind randomised controlled trial [abstract]. J Am Soc Nephrol 2003; 14:54A.
43. Al-Hwiesh AK, Abdul-Rahman IS. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin. Saudi J Kidney Dis Transpl 2007; 18:239-47.
44. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004; 19:1546-51.
45. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 2005; 26:520-4.
46. Cooper R, Saad T. Prevention of bacteraemia in patients with tunneled cuffed quot;permanentquot; hemodialysis catheters (PCs) using gentamicin catheter packing [abstract]. J Am Soc Nephrol 1999; 10:203A.
47. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002; 13:2133-9.
48. Duncan N, Singh S, Amao M. A single centre randomized control trial of sodium citrate versus heparin line locks for cuffed central venous catheters. J Am Soc Nephrol 2005; 16:451A.
49. Hendrickx L, Kuypers D, Evenepoel P, Maes B, Messiaen T, Vanrenterghem Y. A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters. Int J Artif Organs 2001; 24:208-11.
50. Kim SH, Song KI, Chang JW, et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int 2006; 69:161-4.
51. MacRae JM, Dojcinovic I, Jung J, Shalansky S, Levin A, Kiaii M. 4% Citrate vs Heparin and the Reduction of Thrombosis Study (CHARTS) [abstract SA-PO057]. In: Programs and abstracts of Renal Week (San Diego). 2006.
52. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 2004; 66:801-5.
53. Nori US, Manoharan A, Yee J, Besarab A. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 2006; 48:596-605.
54. Pervez A, Ahmed M, Ram S, et al. Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. J Vasc Access 2002; 3:108-13.
55. Saxena AK, Panhotra BR. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study. J Nephrol 2005; 18:755-63.
56. Saxena AK, Panhotra BR, Sundaram DS, Morsy MN, Al-Ghamdi AM. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial. Nephrology (Carlton) 2006; 11:299-305.
57. Weijmer MC, van den Dorpel MA, Van de Ven PJ, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 2005; 16:2769-77.
58. Zhang P, Zhang W, He Q, et al. A randomized controlled study on prevention of cuff-tunneled catheter related bacteremia with gentamicin-heparin lock solution: the metaphase result [abstract SA-PO073]. In: Programs and abstracts of Renal Week (San Diego). 2006.
59. Safdar N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 2006; 43:474-84.
60. Pfaller MA, Jones RN, Doern GV, Sader HS, Kugler KC, Beach ML. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group. Diagn Microbiol Infect Dis 1999; 33:283-97.
61. Rhomberg PR, Jones RN. Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report fromthe United States component (2005). Diagn Microbiol Infect Dis 2007; 57:207-15.
62. Bleyer AJ. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin J Am Soc Nephrol 2007; 2:1073-8.
63. Saxena AK, Panhotra BR, Naguib M. Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock. Pharmacotherapy 2002; 22:105-8.